You are here : Home / All Sectors / Healthcare / Hospital & Healthcare Services / NARAYANA HRUDAYALAYA

NARAYANA HRUDAYALAYA
Intrinsic Value | Fundamental Analysis

Returns | 1W : -4.6% , 1M : -5.2%,1Y : 37.4%
BOM : 539551     NSE : NH    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 400.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 8,182.13 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
NARAYANA HRUDAYALAYA -4.6% -5.2% 37.4%
APOLLO HOSPITALS ENTERPRISE 9.9% 9.2% 129.5%
DR LAL PATHLABS -1.6% 18.4% 97.3%
FORTIS HEALTHCARE 3.6% 12.7% 69.3%
METROPOLIS HEALTHCARE 2.3% 30.7% 98.7%
ASTER DM HEALTHCARE 3.6% 6.8% 40.3%
THYROCARE TECHNOLOGIES 0.4% 17.9% 93.8%
SHALBY 9.4% 19.8% 63.6%
KOVAI MEDICAL CENTER & HOSPITAL 5.3% 10.7% 73.4%

FUNDAMENTAL ANALYSIS OF NARAYANA HRUDAYALAYA

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than NARAYANA HRUDAYALAYA Premium


VALUATION OF NARAYANA HRUDAYALAYA

 
Valuation Score
RatioValue
P/E
P/B
P/S
68.78
P/E Calculated based on EPS of 5.82
[ Mar2020 - Consolidated Results ]

7.22
P/B Calculated based on Book Value of 55.42
[ Mar2020 - Consolidated Results ]

2.98
P/S Calculated based on Revenues of 2743.94 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than NARAYANA HRUDAYALAYA Premium


FAIR VALUE OF NARAYANA HRUDAYALAYA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-12%
0%
19%

SHARE PRICE MOMENTUM OF NARAYANA HRUDAYALAYA

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.37
0.43
0.44
0.41
0.63
0.75
0.78
0.72
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
24.91%
194.55%
-256.03%
-1940.33%
-4.44%
1.2%
7.76%
34.76%
QtrlyTrend
2
Latest Qtr: Dec2020

NARAYANA HRUDAYALAYA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 4.4% 13% 55.2%
S&P BSE SMALL CAP -0.1% 0.3% 91.4%
S&P BSE MIDSMALLCAP -0.3% -0.3% 79.7%
S&P BSE 400 MIDSMALLCAP -0.4% -0.8% 81%
S&P BSE 250 SMALLCAP -1% -2.2% 88.2%
S&P BSE ALLCAP -1.1% -2.1% 60%
S&P BSE 500 -1.1% -2.2% 59.1%
NSE Indices1W1M1Y
NIFTY MID SMALL400 -0.7% -1% 81%
NIFTY SMALLCAP250 -0.7% -1.2% 90.7%
NIFTY 500 -1.1% -2.2% 58.6%

FAQ [Frequently Asked Questions]


Is NH good for long term investment?

As on 22-Apr-2021, the Fundamentals of NH are Strong and hence it's good for long term investment! See Financial Performance of NARAYANA HRUDAYALAYA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NH UnderValued or OverValued?

As on 22-Apr-2021, NH is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of NH ?

As on 22-Apr-2021, the Intrinsic Value of NH is Rs. 399.67 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 453.11
Fair Value [Median EV / Sales Model] : Rs. 399.67
Fair Value [Median Price / Sales Model] : Rs. 335.61
Median Fair Value of NH : Rs. 399.67

Is NH trading at a Premium or Discount?

As on 22-Apr-2021, NH is trading at a Premium of 0% based on the Median Intrinsic Value!

Is it right time to buy NH shares?

As on 22-Apr-2021, NH is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Financial Performance of Industry Peers of NH?

Check out Financials of Industry Peers using below links:
Financials of APOLLO HOSPITALS ENTERPRISE LTD
Financials of DR LAL PATHLABS LTD
Financials of FORTIS HEALTHCARE LTD
Financials of METROPOLIS HEALTHCARE LTD
Financials of ASTER DM HEALTHCARE LTD
Financials of THYROCARE TECHNOLOGIES LTD
Financials of SHALBY LTD
Financials of KOVAI MEDICAL CENTER & HOSPITAL LTD
Financials of INDRAPRASTHA MEDICAL CORPORATION LTD
Financials of KMC SPECIALITY HOSPITALS (INDIA) LTD

What are the Frequent Comparisons with NH?

NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs DR LAL PATHLABS LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs METROPOLIS HEALTHCARE LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs ASTER DM HEALTHCARE LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs THYROCARE TECHNOLOGIES LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs SHALBY LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs KOVAI MEDICAL CENTER & HOSPITAL LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs INDRAPRASTHA MEDICAL CORPORATION LTD
NARAYANA HRUDAYALAYA LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs KMC SPECIALITY HOSPITALS (INDIA) LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z